Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02817815Terminated
Open-label trial (5 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Maximal Platelet Aggregation Level at Day 1, Maximal Platelet Disaggregation Level at Day 1 and 4 more. Started Nov 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02817815.